LifeVantage Co. Short Interest Update

LifeVantage Co. (NASDAQ:LFVN) experienced a notable rise in short interest during October. As of October 15th, the total short interest reached 231,100 shares, marking an increase of 13.8% from the 203,000 shares reported on September 30th. This indicates that currently, 2.3% of the company's stock is being short sold. Considering the average trading volume of 94,300 shares, the days-to-cover ratio stands at 2.5 days.

Institutional Inflows and Outflows

Recently, several institutional investors have either increased or decreased their investments in LifeVantage (LFVN). Hillsdale Investment Management Inc. initiated a new stake in LifeVantage during the first quarter worth $76,000. Hantz Financial Services Inc. also secured a new stake in the second quarter, valued at $91,000. In the third quarter, Ritholtz Wealth Management raised its stake in LifeVantage by 62.0%, and now holds 28,666 shares valued at $346,000 after acquiring an additional 10,974 shares. Empowered Funds LLC increased its position in LifeVantage by 8.1% in the first quarter, now owning 76,203 shares valued at $461,000 following the purchase of an extra 5,742 shares. Acadian Asset Management LLC, on the other hand, raised its holdings by 2.8% in the first quarter, now owning 228,088 shares valued at $1,378,000 after buying 6,121 more shares. Currently, institutional investors and hedge funds hold 35.32% of the stock.

LifeVantage Stock Performance

On Tuesday, shares of LFVN fell by $0.51, bringing the price down to $12.98. The trading volume reached 172,827 shares, significantly exceeding the average volume of 59,519. LifeVantage has a market cap of $164.86 million and a P/E ratio of 46.36, with a beta of 0.84. It has a 50-day moving average price of $10.68 and a 200-day moving average of $8.27. The stock has seen a low of $4.20 and a high of $14.71 over the past year.

LifeVantage last reported its quarterly earnings on August 28th, revealing an EPS of $0.14, which fell short of the consensus estimate of $0.21 by $0.07. The company posted a net margin of 1.47% and a return on equity of 27.85%, with revenues recorded at $48.93 million for the quarter.

LifeVantage Announces Dividend

The company also announced a quarterly dividend recently, which was paid on September 17th. Shareholders who were on record as of September 9th received a dividend of $0.04 per share. The ex-dividend date was also on September 9th. This marks a total annualized dividend of $0.16, yielding 1.23%. Currently, LifeVantage's dividend payout ratio stands at 57.14%.

LifeVantage Company Profile

LifeVantage Corporation specializes in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and probiotics, weight management products, and skincare. Their offerings include Protandim, LifeVantage Omega+, LifeVantage ProBio, and several other health supplements designed to support various health aspects, including cognitive function and digestive health.

Further Reading

• Five stocks we like better than LifeVantage
• Find and Profitably Trade Stocks at 52-Week Lows
• Is McDonald's Stock a Smart Buy After Sell-Off and Earnings?
• 3 Healthcare Dividend Stocks to Buy
• QuantumScape: Solid State EV Batteries Nearing Commercialization
• Investing in Travel Stocks Benefits
• MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?

LifeVantage, Stock, Dividends